Therefore, the ICA may be an effective drug to attenuate the TLR4/MyD88/NF-κB and Wnt/β-catenin signaling pathways to suppress tumor cell proliferation in xenograft in mice models. The gene discussed is TLR4; the disease is neoplasm.